The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism

Intensive Care Medicine

Volumn 22, Issue 4, 1996, Pages 353-355

  Webb, S A R ^a   Stott, S ^a   Van Heerden, P V ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Inhaled prostacyclin; Pulmonary embolism; Pulmonary hypertension

Indexed keywords

ADRENALIN; BUFFER; GLYCINE; PROSTACYCLIN; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR;

AEROSOL; AGED; ARTICLE; CASE REPORT; DRUG ADMINISTRATION; DRUG THERAPY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; MALE; PHARMACEUTICS; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; AEROSOLS; AGED; EPOPROSTENOL; HUMANS; HYPERTENSION, PULMONARY; MALE; PULMONARY EMBOLISM; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0029988741     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01700458     Document Type: Article

References (6)

1. Jones DK, Higgenbottom TWJ, Wallwork J (1987) Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin). Br Heart J 57:270-278
2. Rubin CJ, Mendoza J, Hood M, McGown M, Barst R, Williams WB, Diehl JH, Crow J, Lang W (1990) Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomised trial. Ann Intern Med 112:485-491
3. Walmrath D, Scheider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolised prostacyclin in adult respiratory distress syndrom. Lancet 342:961-962
4. McKintyre KM Sasahara AA (1971) The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 28:288-294
5. 2 Aerosol versus nitric oxide for selective pulmonary vasodilatation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25: 329-340
6. Frostell C, Fratocci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047